Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Natures Sunshine Products | NATR | 14. jan 2025 | 14.00 | +0.29 |
Natuzzi ADR | NTZ | 14. jan 2025 | 4.79 | +5.44 |
NatWest ADR | NWG | 14. jan 2025 | 9.58 | +1.59 |
Nauticus Robotics | KITT | 14. jan 2025 | 1.98 | -4.35 |
Nautilus Biotechnology | NAUT | 14. jan 2025 | 1.86 | +1.09 |
Navidea Biopharmaceuticals | NAVB | 14. jan 2025 | 0.00 | 0.00 |
Navient | NAVI | 14. jan 2025 | 13.41 | +3.31 |
Navigator Holdings | NVGS | 14. jan 2025 | 17.11 | +0.18 |
Navios Maritime Partners LP Unit | NMM | 14. jan 2025 | 45.16 | -1.18 |
Navitas Semiconductor | NVTS | 14. jan 2025 | 3.09 | +4.39 |
Naya Biosciences | NAYA | 14. jan 2025 | 0.50 | 0.00 |
Nayax | NYAX | 14. jan 2025 | 33.81 | +0.15 |
NB Bancorp | NBBK | 14. jan 2025 | 17.44 | +2.83 |
NBT Bancorp | NBTB | 14. jan 2025 | 47.04 | +2.75 |
Ncino | NCNO | 14. jan 2025 | 32.98 | +1.35 |
NCR | VYX | 14. jan 2025 | 13.08 | -0.15 |
NCR Atleos When Issued | NATL | 14. jan 2025 | 31.24 | -1.95 |
NCS Multistage | NCSM | 14. jan 2025 | 27.30 | -2.36 |
Nebius Group | NBIS | 14. jan 2025 | 36.89 | 0.00 |
Nektar Therapeutics | NKTR | 14. jan 2025 | 0.90 | -6.38 |
Nelnet | NNI | 14. jan 2025 | 105.17 | +1.14 |
Neogen | NEOG | 14. jan 2025 | 12.00 | -5.03 |
NeoGenomics | NEO | 14. jan 2025 | 13.78 | +9.11 |
Neonode | NEON | 14. jan 2025 | 7.75 | -0.64 |
NeoVolta | NEOV | 14. jan 2025 | 4.21 | +2.68 |
Nephros | NEPH | 14. jan 2025 | 1.50 | -0.90 |
NerdWallet A | NRDS | 14. jan 2025 | 13.77 | -0.15 |
Nerdy A | NRDY | 14. jan 2025 | 1.56 | +1.96 |
Net Lease Office Properties When Issued | NLOP | 14. jan 2025 | 31.58 | +4.67 |
Net Power A | NPWR | 14. jan 2025 | 8.80 | -3.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.